ConductScience.org, home

Paper8736614

Adverse effects of antipsychotic agents. Do newer agents offer advantages?

Owens DG. Drugs, 1996. Cited by 74 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Adverse effects of antipsychotic agents. Do newer agents offer advantages? Papers, record 8736614. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8736614

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adverse effects of antipsychotic agents. Do newer agents offer advantages?
PubMed
Journal
Drugs
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
3.39
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Owens DGD G

Source PubMed

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antipsychotic AgentsMajor topic
SchizophreniaMajor topic
Humans

Source PubMed

References166

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,035,301"Negative symptoms": conceptual and methodological problems.Schizophr Bull1985https://conductscience.org/library/papers/4035301PubMed
27,514,366Risperidone in the treatment of schizophrenia.Am J Psychiatry1994https://conductscience.org/library/papers/7514366PubMed
31,978,477Experiences of long-term treatment with remoxipride: efficacy and tolerability.Acta Psychiatr Scand Suppl1990https://conductscience.org/library/papers/1978477PubMed
41,924,636Effects of amperozide in schizophrenia. An open study of a potent 5-HT2 receptor antagonist.Psychopharmacology (Berl)1991https://conductscience.org/library/papers/1924636PubMed
53,358,462Deficit and nondeficit forms of schizophrenia: the concept.Am J Psychiatry1988https://conductscience.org/library/papers/3358462PubMed
65,100,620Agranulocytosis, leukopenia, and psychotropic drugs.Arch Gen Psychiatry1971https://conductscience.org/library/papers/5100620PubMed
78,515,788Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.N Engl J Med1993https://conductscience.org/library/papers/8515788PubMed
81,358,126PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients.Br J Psychiatry Suppl1992https://conductscience.org/library/papers/1358126PubMed
97,527,886Risperidone-induced neuroleptic malignant syndrome in young patient.Lancet1994https://conductscience.org/library/papers/7527886PubMed
108,301,292Acute dystonia due to clozapine.J Neurol Neurosurg Psychiatry1994https://conductscience.org/library/papers/8301292PubMed
111,976,107The European experience with use of clozapine.Hosp Community Psychiatry1990https://conductscience.org/library/papers/1976107PubMed
121,352,050A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.Psychopharmacology (Berl)1992https://conductscience.org/library/papers/1352050PubMed
131,903,0195-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.Acta Psychiatr Scand1991https://conductscience.org/library/papers/1903019PubMed
147,537,287Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.J Clin Psychopharmacol1995https://conductscience.org/library/papers/7537287PubMed
157,908,676Clozapine treatment after agranulocytosis induced by classic neuroleptics.J Clin Psychopharmacol1994https://conductscience.org/library/papers/7908676PubMed
162,568,378Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics.Int Clin Psychopharmacol1989https://conductscience.org/library/papers/2568378PubMed
171,675,900The effects of clozapine on tardive dyskinesia.Br J Psychiatry1991https://conductscience.org/library/papers/1675900PubMed
187,961,551Motor and mental side effects of clozapine.J Clin Psychiatry1994https://conductscience.org/library/papers/7961551PubMed
191,978,483Neuropharmacological and behavioural properties of remoxipride in the rat.Acta Psychiatr Scand Suppl1990https://conductscience.org/library/papers/1978483PubMed
207,520,908Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.J Clin Psychiatry1994https://conductscience.org/library/papers/7520908PubMed

See all 166 references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
35,720,508Clozapine blood level assessment using a point-of-care device: feasibility and reliability.Ther Adv Psychopharmacol2022https://conductscience.org/library/papers/35720508PubMed
20,865,083Antipsychotics and risk of venous thromboembolism: A population-based case-control study.Clin Epidemiol2009https://conductscience.org/library/papers/20865083PubMed
14,647,964Neuroleptic dysphoria: towards a new synthesis.Psychopharmacology (Berl)2004https://conductscience.org/library/papers/14647964PubMed
12,383,032Antipsychotic-induced venous thromboembolism: a review of the evidence.CNS Drugs2002https://conductscience.org/library/papers/12383032PubMed
11,607,043Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist.CNS Drug Rev2001https://conductscience.org/library/papers/11607043PubMed
10,843,459Biotransformation of post-clozapine antipsychotics: pharmacological implications.Clin Pharmacokinet2000https://conductscience.org/library/papers/10843459PubMed
9,683,987Risperidone-induced photosensitivity.Postgrad Med J1998https://conductscience.org/library/papers/9683987PubMed
9,098,656Drug-induced movement disorders.Drug Saf1997https://conductscience.org/library/papers/9098656PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8736614

GET https://conductscience.org/api/papers/v1/8736614/references?page=2